'The tool — a type of ‘base editor’ — modified the target gene in more than 90% of an Escherichia coli colony inside the mouse gut. “We were dreaming of being able to do that,” says Xavier Duportet, a synthetic biologist who co-founded Eligo Bioscience, a biotechnology company in Paris. The findings were published today in Nature.'
https://www.nature.com/articles/d41586-024-02238-3
Thiago Carvalho /
npub1xa…czham
2024-07-12 14:22:24
Author Public Key
npub1xakev87fgm9edqu6f5jhszwunekjxl3dpnq4sxvm3nzu2ace8xnqyczhamPublished at
2024-07-12 14:22:24Event JSON
{
"id": "aabb2bbc61c9fc26a923817063a2055b9e848b575b43861efcfc09d33d551833",
"pubkey": "376d961fc946cb96839a4d257809dc9e6d237e2d0cc158199b8cc5c5771939a6",
"created_at": 1720794144,
"kind": 1,
"tags": [
[
"proxy",
"https://qoto.org/users/cyrilpedia/statuses/112773965070200543",
"activitypub"
]
],
"content": "'The tool — a type of ‘base editor’ — modified the target gene in more than 90% of an Escherichia coli colony inside the mouse gut. “We were dreaming of being able to do that,” says Xavier Duportet, a synthetic biologist who co-founded Eligo Bioscience, a biotechnology company in Paris. The findings were published today in Nature.'\n\nhttps://www.nature.com/articles/d41586-024-02238-3",
"sig": "6c795971eb26d11d770529ff25cd9282790555cf75294c50b4f59834e3f5821ecc8ae7deca5e0ebbba9854f428b9b4225245f16ab33e3c84c5442154f3303c03"
}